Evidence map›Paper›PMID 36039394›Full record

ArticlePediatric pulmonology2022

Social determinants of health screening and intervention: A cystic fibrosis quality improvement process.

Deirdre Jennings, Rhonda List, Heather Bruschwein, Martina Compton, Lindsay Somerville, Lauren Williamson, Rachel Murray, Brielle Evangelista, Dana Albon

Open access · greenAbstract read
In one paragraph

Article in Pediatric pulmonology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Deirdre JenningsDepartment of Social Work, University of Virginia Health System, Charlottesville, Virginia, USA.ORCID 0000-0002-5063-1535
Rhonda ListDepartment of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia Health System, Charlottesville, Virginia, USA.ORCID 0000-0002-0385-7400
Heather BruschweinDepartment of Psychiatry and Neurobehavioral Sciences, University of Virginia Health System, Charlottesville, Virginia, USA.ORCID 0000-0003-1180-5149
Martina ComptonDepartment of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia Health System, Charlottesville, Virginia, USA.
Lindsay SomervilleDepartment of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia Health System, Charlottesville, Virginia, USA.ORCID 0000-0001-7052-0640
Lauren WilliamsonDepartment of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia Health System, Charlottesville, Virginia, USA.
Rachel MurrayDepartment of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia Health System, Charlottesville, Virginia, USA.
Brielle EvangelistaDepartment of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia Health System, Charlottesville, Virginia, USA.
Dana AlbonDepartment of Internal Medicine, Division of Pulmonary and Critical Care, University of Virginia Health System, Charlottesville, Virginia, USA.ORCID 0000-0001-9055-3247
University of Virginia Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLower socioeconomic status is associated with significantly poorer outcomes in weight, lung function, and pulmonary exacerbation rates in people with cystic fibrosis (PwCF). GLOBAL

aimWe aim to reduce health disparities and inequities faced by PwCF by screening for and addressing unmet social needs. SPECIFIC

aimsWe aimed to increase routine social determinants of health (SDoH) screening of eligible PwCF from 0% to 95% and follow-up within 2 weeks for those PwCF who screened positive and requested assistance from 0% to 95% by December 31, 2021.

methodsThe Model for Improvement methodology was used. A process map and a simplified failure mode effects analysis chart were created for the screening and SDoH follow-up process. For those who screened positive for SDoH and requested assistance, follow-up contact was made to offer intervention.

interventionAdult PwCF who had at least one UVA Clinic encounter in 2021 were screened for SDoH. The SDoH screening tool included eight domains: housing, food, transportation, utilities, health-care access, medication access, income/employment, and education. Follow-up was completed with all PwCF who screened positive for SDoH.

resultsA total of 132 of 142 (93.0%) PwCF eligible for screening completed the SDoH screening. Of the PwCF who completed screening, 56 (42.4%) screened positive for SDoH. A follow-up rate of 100% was achieved in June 2021 and maintained through December 2021.

conclusionImplementing screening for SDOH and follow-up to mitigate social difficulties in adult PwCF at UVA was successful and could be reproduced at other CF care centers.

Indexed as

Cystic FibrosisSocial Determinants of HealthAdultHumansIncomeMass ScreeningQuality Improvementcystic fibrosisModel for ImprovementPlan-Do-Study-Actsocial determinants of healthsocial risk factors

Identifiers

PMID36039394
PMCPMC9826285
OpenAlexW4293538889

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.